{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:59:48Z","timestamp":1785207588805,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-182A-027"],"award-info":[{"award-number":["111-2314-B-182A-027"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["109-2314-B-182A-009-MY2"],"award-info":[{"award-number":["109-2314-B-182A-009-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-182-070-MY3"],"award-info":[{"award-number":["112-2314-B-182-070-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CORPG8P0561"],"award-info":[{"award-number":["CORPG8P0561"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG8P0631"],"award-info":[{"award-number":["CMRPG8P0631"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["BMRPJ30"],"award-info":[{"award-number":["BMRPJ30"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG8N0881"],"award-info":[{"award-number":["CMRPG8N0881"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pnpbp.2026.111764","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:26:03Z","timestamp":1780417563000},"page":"111764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of Esketamine use with mortality and clinical outcomes in patients with cancer-related depression: A target trial emulation"],"prefix":"10.1016","volume":"147","author":[{"given":"Jen-Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ya","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Tao","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Sung","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111764_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109668","article-title":"The role of NMDA receptor in neurobiology and treatment of major depressive disorder: evidence from translational research","volume":"94","author":"Amidfar","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"18","key":"10.1016\/j.pnpbp.2026.111764_bb0010","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.23.00293","article-title":"Management of anxiety and depression in adult survivors of cancer: ASCO guideline update","volume":"41","author":"Andersen","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111764_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbi.2010.10.008","article-title":"Immune suppression and immune activation in depression","volume":"25","author":"Blume","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2026.111764_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2016.11.004","article-title":"Depression in cancer: the many biobehavioral pathways driving tumor progression","volume":"52","author":"Bortolato","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111764_bb0025","doi-asserted-by":"crossref","first-page":"e190979","DOI":"10.1001\/jamanetworkopen.2019.0979","article-title":"Analysis of diagnoses, symptoms, medications, and admissions among patients with cancer presenting to emergency departments","volume":"2","author":"Caterino","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111764_bb0030","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41591-022-01740-3","article-title":"Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers","volume":"28","author":"Chang","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2026.111764_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109351","article-title":"Ketamine, benzoate, and sarcosine for treating depression","volume":"223","author":"Cheng","year":"2023","journal-title":"Neuropharmacol."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111764_bb0040","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/ijms19102888","article-title":"Eradicating suicide at its roots: preclinical bases and clinical evidence of the efficacy of ketamine in the treatment of suicidal behaviors","volume":"19","author":"De Berardis","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111764_bb0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2174\/1568026620666200131100316","article-title":"An update on glutamatergic system in suicidal depression and on the role of esketamine","volume":"20","author":"De Berardis","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pnpbp.2026.111764_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105796","article-title":"Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: a systematic review of animal models of depression","volume":"164","author":"De Jager","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111764_bb0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2026.111764_bb0060","first-page":"756","article-title":"Cancer tissue procoagulant mechanisms and the hypercoagulable state of patients with cancer","author":"Falanga","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111764_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1176\/appi.ajp.20240515","article-title":"Esketamine treatment for depression in adults: a PRISMA systematic review and meta-analysis","volume":"182","author":"Fountoulakis","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111764_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/DDDT.S504179","article-title":"Esketamine at a clinical dose attenuates cerebral ischemia\/reperfusion injury by inhibiting AKT signaling pathway to facilitate microglia M2 polarization and autophagy","author":"Gao","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111764_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000510703","article-title":"Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system","volume":"90","author":"Gastaldon","year":"2020","journal-title":"Psychother. Psychosom."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111764_bb0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12888-025-06599-5","article-title":"Global prevalence and determinant factors of pain, depression, and anxiety among cancer patients: an umbrella review of systematic reviews and meta-analyses","volume":"25","author":"Getie","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111764_bb0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-981-19-7376-5_21","article-title":"The glutamatergic system in treatment-resistant depression and comparative effectiveness of ketamine and esketamine: role of inflammation?","volume":"1411","author":"Halaris","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111764_bb0090","first-page":"3419","article-title":"Patient-reported distress as an early warning sign of unmet palliative care needs and increased healthcare utilization in patients with advanced cancer","volume":"30","author":"Hildenbrand","year":"2022","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111764_bb0095","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00406-024-01865-1","article-title":"Esketamine in depression: putative biomarkers from clinical research","volume":"275","author":"Johnston","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111764_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111764_bb0105","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2026.10164","article-title":"Network localization of brain functional effects of ketamine treatment for major depression","volume":"69","author":"Ma","year":"2026","journal-title":"Eur. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111764_bb0110","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/pon.4133","article-title":"Depression and healthcare service utilization in patients with cancer","volume":"26","author":"Mausbach","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.pnpbp.2026.111764_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66059-2","article-title":"Mediators of the association between psychological distress and mortality in people diagnosed with cancer","author":"Miller","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111764_bb0120","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14740338.2022.2066651","article-title":"Long-term safety of ketamine and esketamine in treatment of depression","volume":"21","author":"Nikayin","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.pnpbp.2026.111764_bb0125","article-title":"Antidepressants for the treatment of depression in people with cancer","volume":"4","author":"Ostuzzi","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111764_bb0130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1176\/appi.ajp.20240655","article-title":"Real-world safety of esketamine nasal spray: a comprehensive analysis almost 5 years after first approval","volume":"182","author":"Sanacora","year":"2025","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111764_bb0135","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1097\/MS9.0000000000003232","article-title":"Safety considerations and risk mitigation strategies for ketamine use: a comprehensive review","volume":"87","author":"Sayad","year":"2025","journal-title":"Ann. Med. Surg."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111764_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10286-018-0523-1","article-title":"Autonomic nervous system and cancer","volume":"28","author":"Sim\u00f3","year":"2018","journal-title":"Clin. Auton. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111764_bb0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/09540261.2013.875891","article-title":"The biology of depression in cancer and the relationship between depression and cancer progression","volume":"26","author":"Sotelo","year":"2014","journal-title":"Int. Rev. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111764_bb0150","first-page":"131","article-title":"Adjunctive intranasal Esketamine for comorbid treatment-resistant depression with suicidal ideation in patients receiving palliative Care at a Comprehensive Cancer Center: a Case series","volume":"28","author":"Tomy","year":"2025","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.pnpbp.2026.111764_bb0155","first-page":"1","article-title":"Depression increases cancer mortality by 23\u201383%: a meta-analysis of 65 studies across five major cancer types","author":"Ungvari","year":"2025","journal-title":"Geroscience"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111764_bb0160","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cpt.3478","article-title":"Ketamine and Esketamine in clinical trials: FDA-approved and emerging indications, trial trends with putative mechanistic explanations","volume":"117","author":"Vekhova","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111764_bb0165","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41380-019-0595-x","article-title":"Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies","volume":"25","author":"Wang","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111764_bb0170","article-title":"The impact of depression on the quality of life of lung cancer patients undergoing chemotherapy: mediating effects of perceived social support","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111764_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-026-03929-3","article-title":"Brain functional network correlates and predictors of the perioperative antidepressant effect of esketamine in breast cancer patients: a double-blind randomized controlled trial using resting-state fMRI and graph theory","volume":"16","author":"Zhu","year":"2026","journal-title":"Transl. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626001612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:35:01Z","timestamp":1785206101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626001612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S0278584626001612"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111764","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Esketamine use with mortality and clinical outcomes in patients with cancer-related depression: A target trial emulation","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111764"}}